Vital Therapies Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

Vital Therapies General Information

Description

Immunic Inc is a clinical stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing remitting multiple sclerosis, and psoriasis. The company is developing three small molecule products, IMU-838 is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH, IMU-935 is an inverse agonist of RORγt and IMU-856 targets the restoration of the intestinal barrier function.

Contact Information

Website
www.vitaltherapies.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 15010 Avenue of Science
  • Suite 200
  • San Diego, CA 92128
  • United States
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Acquirer
Immunic Therapeutics
Vertical(s)
Life Sciences
Corporate Office
  • 15010 Avenue of Science
  • Suite 200
  • San Diego, CA 92128
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vital Therapies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Merger/Acquisition 12-Apr-2019 Completed Generating Revenue
11. 2PO 23-Mar-2017 Completed Generating Revenue
10. IPO 17-Apr-2014 Completed Generating Revenue
9. Later Stage VC 05-Mar-2014 Completed Generating Revenue
8. Later Stage VC 31-Jan-2014 Completed Generating Revenue
7. Later Stage VC 06-Nov-2012 Completed Clinical Trials - Phase 3
6. Later Stage VC 23-Feb-2012 Completed Generating Revenue
5. Later Stage VC (Series D) 30-Jun-2011 Completed Generating Revenue
4. Later Stage VC 21-Jun-2011 $16.2M $43.7M Completed Generating Revenue
3. Later Stage VC (Series C) 11-Sep-2007 $28.1M $43.7M Completed Generating Revenue
To view Vital Therapies’s complete valuation and funding history, request access »

Vital Therapies Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series C
Series B
Series A 6,332,250 $0.000100 6% $1 $1 1x $1 4.32%
To view Vital Therapies’s complete cap table history, request access »

Vital Therapies Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Immunic Inc is a clinical stage biopharmaceutical company developing a pipeline of selective oral immunology therapies a
Biotechnology
San Diego, CA

Plymouth Meeting, PA
 

Abingdon, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Vital Therapies Competitors (37)

One of Vital Therapies’s 37 competitors is Inovio Pharmaceuticals, a Corporation company based in Plymouth Meeting, PA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Inovio Pharmaceuticals Corporation Plymouth Meeting, PA
Immunocore Holdings Formerly VC-backed Abingdon, United Kingdom
HepaRegenix Venture Capital-Backed Tubingen, Germany
Cellaion Formerly VC-backed Mont-Saint-Guibert, Belgium
uniQure Formerly VC-backed Amsterdam, Netherlands
You’re viewing 5 of 37 competitors. Get the full list »

Vital Therapies Patents

  • 4

    Total Documents Applications and Grants

  • Total Patents Families

  • 1

    Granted

  • Pending

  • Expiring in next 12 mo

Vital Therapies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
FR-3047492-A1 Knitting device and method for producing knitted article and knitted article produced according to such a knitting process Active 10-Feb-2016
FR-3047492-B1 Knitting device and method for producing knitted article and knitted article produced according to such a knitting process Inactive 10-Feb-2016
EP-3414379-A1 Knitting facility and method for producing a knitted item and knitted item produced according to such a knitting method Inactive 10-Feb-2016
WO-2017137691-A1 Knitting facility and method for producing a knitted item and knitted item produced according to such a knitting method Inactive 10-Feb-2016 D04B23/16

Vital Therapies Former Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
DFJ DragonFund China Venture Capital Minority
Delphi Ventures (California) Venture Capital Minority
Draper Dragon Venture Capital Minority
Draper Fisher Jurvetson Management Venture Capital Minority
EW Healthcare Partners Growth/Expansion Minority
You’re viewing 5 of 14 investors. Get the full list »

Vital Therapies Acquisitions (2)

Vital Therapies’s most recent deal was a Reverse Merger with Immunic Therapeutics. The deal was made on 12-Apr-2019.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Immunic Therapeutics 12-Apr-2019 Reverse Merger Drug Discovery
VitaGen 01-Oct-2003 Merger/Acquisition Other Devices and Supplies
To view Vital Therapies’s complete acquisitions history, request access »

Ready to get started?

Request a free trial

Vital Therapies FAQs

  • When was Vital Therapies founded?

    Vital Therapies was founded in 2003.

  • Where is Vital Therapies headquartered?

    Vital Therapies is headquartered in San Diego, CA.

  • What industry is Vital Therapies in?

    Vital Therapies’s primary industry is Biotechnology.

  • Is Vital Therapies a private or public company?

    Vital Therapies is a Private company.

  • What is Vital Therapies’s current revenue?

    The current revenue for Vital Therapies is .

  • How much funding has Vital Therapies raised over time?

    Vital Therapies has raised $265M.

  • Who are Vital Therapies’s investors?

    DFJ DragonFund China, Delphi Ventures (California), Draper Dragon, Draper Fisher Jurvetson Management, and EW Healthcare Partners are 5 of 14 investors who have invested in Vital Therapies.

  • Who are Vital Therapies’s competitors?

    Inovio Pharmaceuticals, Immunocore Holdings, HepaRegenix, Cellaion, and uniQure are some of the 37 competitors of Vital Therapies.

  • When was Vital Therapies acquired?

    Vital Therapies was acquired on 12-Apr-2019.

  • Who acquired Vital Therapies?

    Vital Therapies was acquired by Immunic Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process